Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! 

China Clinical Trials 2017

Analysis of IND and NDA applications and approvals in China 2011-2017

Download free report on life science investment in China

In My Opinion

Sometimes our Executive Editor, Greg B. Scott, can't help himself, and he has to either report on some tidbit or rumor he's heard, or voice his opinion.  So here are his proclamations on biotech, China, and anything else he feels passionate about...

China View: JP Morgan Healthcare Conference, 2013
China at JP Morgan Conference - A Few Observations
Charles River’s Decision Shows Misunderstanding of Pharma’s Future
China’s Opportunity to Create Mega-Clusters
In My Opinion: China vs. the Economy - Is it China's Time?
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Events
The 9th China Healthcare Investment Conference
Shanghai, China
March 27-29, 2018
Use chinabio18 for 20% discount